Paclitaxel shows interesting clinical activity against sever al tumors
. However, its poor solubility is an important limitation: Cremophor E
L used for intravenous administration is responsible for hypersensitiv
ity reactions. In order to improve solubility while preserving the act
ivity, we have synthesized new paclitaxel amino acid derivatives subst
ituted with a glutaryl group at the 2' position followed by the reacti
on of a peptide link between the carboxyl and the amino terminal group
of the amino acid. The derivatives were cytotoxic in vitro against ma
ny sensitive cell lines. They also increased G(2)+M phase arrest Moreo
ver these derivatives were stable for over a year and showed a better
solubility in water than the parent compound. The ester linkage is hyd
rolysed in slightly acid lysosomal conditions to free paclitaxel which
binds to tubulin.